Literature DB >> 29345347

Interferons and beyond: Induction of antiretroviral restriction factors.

Dominik Hotter1, Frank Kirchhoff1.   

Abstract

Antiviral restriction factors are structurally and functionally diverse cellular proteins that play a key role in the first line of defense against viral pathogens. Although many cell types constitutively express restriction factors at low levels, their induction in response to viral exposure and replication is often required for potent control and repulse of the invading pathogens. It is well established that type I IFNs efficiently induce antiviral restriction factors. Accumulating evidence suggests that other types of IFN, as well as specific cytokines, such as IL-27, and other activators of the cell are also capable of enhancing the expression of restriction factors and hence to establish an antiviral cellular state. Agents that efficiently induce restriction factors, increase their activity, and/or render them resistant against viral antagonists without causing general inflammation and significant side effects hold some promise for novel therapeutic or preventive strategies. In the present review, we summarize some of the current knowledge on the induction of antiretroviral restriction factors and perspectives for therapeutic application. ©2017 Society for Leukocyte Biology.

Entities:  

Keywords:  antiviral state; cytokines; innate immunity; viral pathogens

Mesh:

Substances:

Year:  2017        PMID: 29345347     DOI: 10.1002/JLB.3MR0717-307R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  PSGL-1 inhibits HIV-1 infection by restricting actin dynamics and sequestering HIV envelope proteins.

Authors:  Ying Liu; Yutong Song; Siyu Zhang; Min Diao; Shanjin Huang; Sai Li; Xu Tan
Journal:  Cell Discov       Date:  2020-08-04       Impact factor: 10.849

2.  Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages.

Authors:  Mei-Rong Wang; Di-Di Wu; Fan Luo; Chao-Jie Zhong; Xin Wang; Ni Zhu; Ying-Jun Wu; Hai-Tao Hu; Yong Feng; Xu Wang; Hai-Rong Xiong; Wei Hou
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

Review 3.  Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways.

Authors:  Ugo Moens; Andrew Macdonald
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

Review 4.  Tuning the Orchestra: HCMV vs. Innate Immunity.

Authors:  Valentina Dell'Oste; Matteo Biolatti; Ganna Galitska; Gloria Griffante; Francesca Gugliesi; Selina Pasquero; Alessandra Zingoni; Cristina Cerboni; Marco De Andrea
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

Review 5.  P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target.

Authors:  Silvere D Zaongo; Yanqiu Liu; Vijay Harypursat; Fangzhou Song; Huan Xia; Ping Ma; Yaokai Chen
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

Review 6.  The Role and Impact of Extracellular Vesicles in the Modulation and Delivery of Cytokines during Autoimmunity.

Authors:  Mohammed Tayab Hussain; Asif Jilani Iqbal; Lucy Victoria Norling
Journal:  Int J Mol Sci       Date:  2020-09-26       Impact factor: 5.923

Review 7.  Platelets in Immune Response to Virus and Immunopathology of Viral Infections.

Authors:  Eugenio D Hottz; Fernando A Bozza; Patrícia T Bozza
Journal:  Front Med (Lausanne)       Date:  2018-04-30

8.  Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner.

Authors:  Sarah Maillet; Juliette Fernandez; Mathilde Decourcelle; Khadija El Koulali; Fabien P Blanchet; Nathalie J Arhel; Ghizlane Maarifi; Sébastien Nisole
Journal:  Viruses       Date:  2020-06-11       Impact factor: 5.048

Review 9.  Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles.

Authors:  Betsy J Barnes; Carter C Somerville
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

Review 10.  KSHV: Immune Modulation and Immunotherapy.

Authors:  Grant Broussard; Blossom Damania
Journal:  Front Immunol       Date:  2020-02-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.